Prednisolone reduces sequelae in Bell's Palsy
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Patients treated for Bell palsy with prednisolone within 72 hours achieved significantly reduced severity of mild to… read more.
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Patients treated for Bell palsy with prednisolone within 72 hours achieved significantly reduced severity of mild to… read more.
A meta-analysis confirms that statin therapy lowers the risk of major vascular events by about a fifth among subjects with no history of vascular disease, male and female,… read more.
Studies have shown that the offspring of mothers on a low-protein diet are more likely to develop hypertension as adults.
by Thomas R. Collins – Injection of regulatory T cells could prove to be a powerful method of inducing tolerance among liver transplantation patients,
by Thomas R. Collins – The state of treatment for Hepatitis C patients waiting for a liver transplant leaves a lot to be desired
by Thomas R. Collins – Doing a biopsy on a liver before the organ is procured for transplantation is helpful only when done for certain potential organ donors,
by Thomas R. Collins – With a scarcity of livers available for transplantation, there is a tremendous pressure on the medical community to make the best use of… read more.
by Thomas R. Collins – A living donor liver transplant can be a safe and effective first-line treatment for very young children with biliary atresia,
Dr Irene Scalera, Fellow at the Liver Unit at Queen Elizabeth Hospital, Birmingham, describes the ever-changing donor landscape and attempts to improve liver donor shortage.
Findings from a newly published meta-analysis suggests that levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin users is associated with risk of developing a major cardiovascular event, such… read more.
Paper presented on 5th June at ASCO – by Bruce Sylvester – The antidepressant duloxetine (Cymbalta ®), relieves neuropathic pain caused by chemotherapy in 59 percent of patients,… read more.
by Bruce Sylvester – Researchers from a Phase III study report no difference in rates of viral clearance between two anemia management strategies for patients with chronic hepatitis… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.